Company Registration No. 07022309 (England and Wales)
NORTHWOOD TISSUE (DISLEY) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 DECEMBER 2024
Star House
Star Hill
Rochester
Kent
ME1 1UX
NORTHWOOD TISSUE (DISLEY) LIMITED
CONTENTS
Page
Company information
1
Strategic report
2 - 3
Directors' report
4 - 5
Independent auditor's report
6 - 9
Statement of comprehensive income
10
Statement of financial position
11 - 12
Statement of changes in equity
13
Statement of cash flows
14
Notes to the financial statements
15 - 30
NORTHWOOD TISSUE (DISLEY) LIMITED
COMPANY INFORMATION
- 1 -
Directors
Mr P Fecher
Mr M Fecher
Mr A Fecher
Mr P King
Mr C Davies
Mr D Harries
Secretary
Mr P E King
Company number
07022309
Registered office
Waterside
Disley
Stockport
SK12 2HW
Auditor
TC Group
Star House
Star Hill
Rochester
Kent
ME1 1UX
NORTHWOOD TISSUE (DISLEY) LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -

The directors present the strategic report for the year ended 31 December 2024.

 

Introduction

 

During the year under review, the company’s principal trading activity has continued to be the manufacture of paper tissue and towel parent reels. The Northwood AfH Group* operates 3 recycled paper mills with the capacity to service the internal parent reel requirements of the Group’s converting operations.

Fair review of the business

 

Although there was an upside from lower energy costs and production levels were on par with the previous year. The erosion of the selling price, which was down ~£100/t, and inflationary cost pressures elsewhere in the supply chain meant lower overall profitability in FY24 compared to the previous year. As part of the continued investment in sustainability and energy efficiency, the site invested ~£1m in the latest boiler technology for generating the steam. We should see the full benefits of this capital expenditure in FY25.

 

Supply of parent reels to associated companies remained at 99% of production volume in the year with overall production being 8% down on budget. Overall tonnes produced was up 4% from FY23 but the lower selling price noted above meant turnover was down £765k compared to FY23. The gross profit percentage was down to 12.7% [17.4% in 2023] and there was an operating profit of £1,207k [£2,367 in 2023].

 

Principal risks and uncertainties

The company does not operate in a high‑risk environment and the nature of the vertically integrated supply chain that the company works within, along with related companies who are either suppliers or customers, ensures that there is not an over‑reliance on any specific external supplier or customer. The nature of commercial markets means that where sales are made outside the Group, there is a focus on the credit management controls required to minimise the risk of bad debts and to ensure the smooth flow of product. The company continues to comply with all relevant environmental and industry legislation and this is facilitated through continued membership of the CPI. The company has been accredited with the Ecolabel standard meaning that Ecolabel certified products can be manufactured at the company’s related converting plants using base sheet supplied by the business.

NORTHWOOD TISSUE (DISLEY) LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
Key performance indicators

On behalf of the board

Mr C Davies
Director
14 September 2025
NORTHWOOD TISSUE (DISLEY) LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the company continued to be that of the manufacture of paper tissue and towel parent reels.

Results and dividends

The results for the year are set out on page 10.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr P Fecher
Mr M Fecher
Mr A Fecher
Mr P King
Mr C Davies
Mr D Harries
Auditor

The auditor, TC Group, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

NORTHWOOD TISSUE (DISLEY) LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 5 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

On behalf of the board
Mr C Davies
Director
14 September 2025
NORTHWOOD TISSUE (DISLEY) LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF NORTHWOOD TISSUE (DISLEY) LIMITED
- 6 -
Opinion

We have audited the financial statements of Northwood Tissue (Disley) Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of comprehensive income, the statement of financial position, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

NORTHWOOD TISSUE (DISLEY) LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF NORTHWOOD TISSUE (DISLEY) LIMITED
- 7 -

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

 

Extent to which the audit was considered capable of detecting irregularities, including fraud

The objectives of our audit, in respect to fraud, are: to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses; and to respond appropriately to fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the entity and its management.

 

NORTHWOOD TISSUE (DISLEY) LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF NORTHWOOD TISSUE (DISLEY) LIMITED
- 8 -

Our approach was as follows:

 

 

Based on this understanding we designed our audit procedures to identify non-compliance with such laws and regulations. Where the risk was considered to be higher, we performed audit procedures to address each identified fraud risk. These procedures included: testing manual journals; reviewing the financial statement disclosures and testing to supporting documentation; performing analytical procedures; and enquiring of management, and were designed to provide reasonable assurance that the financial statements were free from fraud or error.

 

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, the further removed non-compliance with laws and regulations (irregularities) is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by auditing standards would identify it. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation. We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations.

A further description of our responsibilities is available on the FRC’s website at: https://www.frc.org.uk/auditors/audit-assurance/auditor-s-responsibilities-for-the-audit-of-the-fi/description-of-the-auditor%E2%80%99s-responsibilities-for. This description forms part of our auditor’s report.

 

 

NORTHWOOD TISSUE (DISLEY) LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF NORTHWOOD TISSUE (DISLEY) LIMITED
- 9 -

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Sally Meah FCCA (Senior Statutory Auditor)
For and on behalf of TC Group
Statutory Auditor
23 September 2025
Star House
Star Hill
Rochester
Kent
ME1 1UX
NORTHWOOD TISSUE (DISLEY) LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
2024
2023
Notes
£
£
Turnover
3
21,362,239
22,127,072
Cost of sales
(18,647,612)
(18,274,201)
Gross profit
2,714,627
3,852,871
Administrative expenses
(1,507,521)
(1,485,435)
Operating profit
4
1,207,106
2,367,436
Interest receivable and similar income
7
24
996
Interest payable and similar expenses
8
(58,075)
(156,360)
Profit before taxation
1,149,055
2,212,072
Tax on profit
10
(119,284)
(530,542)
Profit for the financial year
1,029,771
1,681,530
Other comprehensive income
Revaluation of tangible fixed assets
-
0
1,668,547
Tax relating to other comprehensive income
34,125
(385,299)
Total comprehensive income for the year
1,063,896
2,964,778

The income statement has been prepared on the basis that all operations are continuing operations.

The notes on pages 15 to 30 form part of these financial statements.

NORTHWOOD TISSUE (DISLEY) LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024
31 December 2024
- 11 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
11
9,552,727
8,836,151
Current assets
Stocks
12
1,445,089
1,259,775
Debtors
13
7,641,240
9,108,541
Cash at bank and in hand
28,859
235,362
9,115,188
10,603,678
Creditors: amounts falling due within one year
14
(5,651,911)
(6,243,421)
Net current assets
3,463,277
4,360,257
Total assets less current liabilities
13,016,004
13,196,408
Creditors: amounts falling due after more than one year
15
-
0
(1,288,947)
Provisions for liabilities
Provisions
17
250,010
250,010
Deferred tax liability
18
1,810,366
1,765,719
(2,060,376)
(2,015,729)
Net assets
10,955,628
9,891,732
Capital and reserves
Called up share capital
20
100
100
Share premium account
99,900
99,900
Non-distributable reserve
2,557,034
2,584,567
Profit and loss reserves
8,298,594
7,207,165
Total equity
10,955,628
9,891,732

The notes on pages 15 to 30 form part of these financial statements.

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

NORTHWOOD TISSUE (DISLEY) LIMITED
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024
31 December 2024
- 12 -
The financial statements were approved by the board of directors and authorised for issue on 14 September 2025 and are signed on its behalf by:
Mr C Davies
Director
Company registration number 07022309 (England and Wales)
NORTHWOOD TISSUE (DISLEY) LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 13 -
Share capital
Share premium account
Non-distributable reserve
Profit and loss reserves
Total
£
£
£
£
£
Balance at 1 January 2023
100
99,900
1,426,567
5,400,387
6,926,954
Year ended 31 December 2023:
Profit
-
-
-
1,681,530
1,681,530
Other comprehensive income:
Revaluation of tangible fixed assets
-
-
1,668,547
-
1,668,547
Tax relating to other comprehensive income
-
-
(385,299)
-
0
(385,299)
Total comprehensive income
-
-
1,283,248
1,681,530
2,964,778
Other movements
-
-
(125,248)
125,248
-
Balance at 31 December 2023
100
99,900
2,584,567
7,207,165
9,891,732
Year ended 31 December 2024:
Profit
-
-
-
1,029,771
1,029,771
Other comprehensive income:
Tax relating to other comprehensive income
-
-
34,125
-
0
34,125
Total comprehensive income
-
-
34,125
1,029,771
1,063,896
Other movements
-
-
(61,658)
61,658
-
Balance at 31 December 2024
100
99,900
2,557,034
8,298,594
10,955,628

The notes on pages 15 to 30 form part of these financial statements.

NORTHWOOD TISSUE (DISLEY) LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 14 -
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
24
3,276,570
1,390,082
Interest paid
(58,075)
(156,360)
Income taxes (paid)/refunded
(453,230)
90,517
Net cash inflow from operating activities
2,765,265
1,324,239
Investing activities
Purchase of tangible fixed assets
(1,068,556)
(657,939)
Proceeds from disposal of tangible fixed assets
15,689
-
0
Interest received
24
996
Net cash used in investing activities
(1,052,843)
(656,943)
Financing activities
Repayment of borrowings
(1,918,925)
(657,692)
Net cash used in financing activities
(1,918,925)
(657,692)
Net (decrease)/increase in cash and cash equivalents
(206,503)
9,604
Cash and cash equivalents at beginning of year
235,362
225,758
Cash and cash equivalents at end of year
28,859
235,362

The notes on pages 15 to 30 form part of these financial statements.

NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 15 -
1
Accounting policies
Company information

Northwood Tissue (Disley) Limited is a private company limited by shares incorporated in England and Wales. The registered office is Waterside, Disley, Stockport, SK12 2HW.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of plant & machinery. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 16 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 17 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 18 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 19 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Provisions

Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 20 -
1.13

Invoice discounting

The company discounts its trade debts. The accounting policy is to include a gross asset for trade debtors due within one year and to record the returnable element of the proceeds under creditors due within one year. Discount fees are charged to the profit and loss account when payable. Bad debts are bourne by the company and charged to the profit and loss account when reasonably foreseeable.

2
Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions in applying the Company's accounting policies to determine the reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates. These estimates and underlying assumptions are reviewed on an ongoing basis.

 

Judqements

Critical judgments, apart from those involving estimations that are applied in the preparation of the consolidated financial statements are discussed below;

 

Leases

Management exercises judgment in determining the classification of leases as finance or operating leases at the inception of the lease. Management considers the likelihood of exercising the break clauses or extension options in determining the lease term. Where the lease term constitutes substantially all the economic life of the asset, or where the present value of minimum lease payments amount to substantially all of the fair value of the property, the lease is classified as a finance lease. All other leases are classified as operating leases.

NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
2
Judgements and key sources of estimation uncertainty
(Continued)
- 21 -

Estimates

The key assumptions about the future and other key sources of estimation uncertainty at the reporting period end that may have a significant risk of causing material adjustment to the carrying amount of assets and liabilities within the next financial year are discussed below;

 

Depreciation of property, plant and equipment

Depreciation is provided so as to write down the assets to their residual values over their estimated useful lives. The selection of these residual values and estimated lives requires the exercise of management judgment.

 

lmpairment of assets

Where there are indicators of impairment, management performs an impairment test. Recoverable amounts for cash-generating units are the higher of fair value less costs of disposal, and value in use.

 

Stock

Stock is stated at the lower of cost and net realisable value. Cost is determined on a first-in, first-out (FIFO) basis and includes all costs of purchase, conversion, and other costs incurred in bringing the inventories to their present location and condition.

 

Judgement is required in assessing the net realisable value of stock, which involves estimating future selling prices and costs necessary to make the sale. In particular, management reviews stock for obsolete, slow-moving, or damaged items and makes appropriate provisions where necessary.

 

Changes in market conditions or customer demand could impact the net realisable value of inventory and result in adjustments to the carrying amount. At the balance sheet date, management considered the stock held and concluded that the provision for obsolete and slow-moving inventory was adequate.

3
Turnover
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
21,362,239
22,127,072
4
Operating profit
2024
2023
Operating profit for the year is stated after charging/(crediting):
£
£
Exchange (gains)/losses
(492)
2,768
Depreciation of owned tangible fixed assets
332,770
352,682
Loss on disposal of tangible fixed assets
3,521
500
Operating lease charges
30,023
20,426
NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 22 -
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Direct staff
28
26
Indirect staff
27
23
Administration staff
6
6
Directors
6
1
Total
67
56

Their aggregate remuneration comprised:

2024
2023
£
£
Wages and salaries
3,033,008
2,880,984
Social security costs
255,438
284,970
Pension costs
114,015
123,331
3,402,461
3,289,285
6
Auditor's remuneration
2024
2023
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
19,555
18,665
7
Interest receivable and similar income
2024
2023
£
£
Interest income
Other interest income
24
996
NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 23 -
8
Interest payable and similar expenses
2024
2023
£
£
Other finance costs:
Other interest
58,075
156,360
9
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
195,131
166,128
Company pension contributions to defined contribution schemes
29,299
27,478
224,430
193,606

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 1 (2023 - 1).

10
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
40,512
453,230
Adjustments in respect of prior periods
-
0
(1,064)
Total current tax
40,512
452,166
Deferred tax
Origination and reversal of timing differences
78,772
78,376
Total tax charge
119,284
530,542
NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
10
Taxation
(Continued)
- 24 -
2024
2023
£
£
Profit before taxation
1,149,055
2,212,072
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 25.00%)
287,264
553,018
Tax effect of expenses that are not deductible in determining taxable profit
2,101
(35,100)
Tax effect of utilisation of tax losses not previously recognised
-
0
(62,219)
Adjustments in respect of prior years
-
0
(1,064)
Effect of change in corporation tax rate
-
0
(28,509)
Permanent capital allowances in excess of depreciation
(248,853)
26,040
Deferred tax adjustment
78,772
78,376
Taxation charge for the year
119,284
530,542

In addition to the amount charged to the income statement, the following amounts relating to tax have been recognised directly in other comprehensive income:

2024
2023
£
£
Deferred tax arising on:
Revaluation of plant and machinery
(34,125)
385,299
NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 25 -
11
Tangible fixed assets
Assets under construction
Plant and equipment
Total
£
£
£
Cost or valuation
At 1 January 2024
544,040
8,292,111
8,836,151
Additions
175,867
892,689
1,068,556
Disposals
-
0
(19,210)
(19,210)
At 31 December 2024
719,907
9,165,590
9,885,497
Depreciation and impairment
At 1 January 2024
-
0
-
0
-
0
Depreciation charged in the year
-
0
332,770
332,770
At 31 December 2024
-
0
332,770
332,770
Carrying amount
At 31 December 2024
719,907
8,832,820
9,552,727
At 31 December 2023
544,040
8,292,111
8,836,151

Plant and machinery with a carrying amount of £8,292,111 was revalued at 19th October 2023 by Hilco Valuation Services, independent valuers on the basis of market value. The valuation conforms to International Valuation Standards and was based on technical and financial information pertaining to the subject assets.

If plant and machinery was measured using the cost model, the carrying amounts would have been approximately £5,456,350 (2023 - £4,779,140), being cost £7,051,042 (2023 - £6,177,563) and depreciation £1,594,692 (2023 - £1,398,423).

12
Stocks
2024
2023
£
£
Raw materials and consumables
629,346
907,603
Finished goods and goods for resale
815,743
352,172
1,445,089
1,259,775
NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 26 -
13
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
2,983,236
2,545,200
Other debtors
3,584,699
5,897,696
Prepayments and accrued income
1,073,305
665,645
7,641,240
9,108,541
14
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Other borrowings
16
-
0
629,978
Trade creditors
2,726,273
2,926,937
Corporation tax
40,512
453,230
Other taxation and social security
273,973
66,955
Other creditors
1,090,302
29,151
Accruals and deferred income
1,520,851
2,137,170
5,651,911
6,243,421
15
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Other borrowings
16
-
0
1,288,947
16
Loans and overdrafts
2024
2023
£
£
Other loans
-
0
1,918,925
Payable within one year
-
0
629,978
Payable after one year
-
0
1,288,947

A general debenture dated 8 January 2010 is held by Northwood Paper Sales Limited. The debenture is a fixed and floating charge over property and assets.

NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 27 -
17
Provisions for liabilities
2024
2023
£
£
Dilapidation provision
250,010
250,010
Movements on provisions:
Dilapidation provision
£
At 1 January 2024 and 31 December 2024
250,010
18
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2024
2023
Balances:
£
£
Accelerated capital allowances
966,248
887,477
Revaluations
844,118
878,242
1,810,366
1,765,719
2024
Movements in the year:
£
Liability at 1 January 2024
1,765,719
Charge to profit or loss
44,647
Liability at 31 December 2024
1,810,366

The deferred tax liability set out above is expected to reverse within 12 months and relates to accelerated capital allowances that are expected to mature within the same period.

NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 28 -
19
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
114,015
123,331

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

20
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
100
100
100
100
21
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2024
2023
£
£
Within one year
422,958
236,508
Between two and five years
1,063,821
336,192
1,486,779
572,700
22
Capital commitments

Amounts contracted for but not provided in the financial statements:

2024
2023
£
£
Acquisition of tangible fixed assets
10,527
243,014
NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 29 -
23
Related party transactions
Transactions with related parties

During the year under review, the following transactions took place with entities over which the entity has significant influence over;

 

Sales of goods and other recharges of £23,345,104 (2023 - £22,061,263);

The balance due at the year end is £2,966,537 (2023 - 2,536,967) and is included in trade debtors.

 

Costs of purchases and other recharges of £6,976,627 (2023 - £7,725,618);

The balance due at the year end is £2,040,940 (2023 - £813,247) and is included in trade creditors, other creditors and accruals.

 

Rent of £323,507 (2023 - £250,000) was paid.

 

Loans of £2,651,833 (2023 - £0) were made;

Loans of £0 (2023 - £0) were received;

Repayments of £4,300,518 (2023 - £1,221,103) were received;

Repayments of £0 (2023 - £1,544,154) were made;

 

As at 31 December 2024 £3,358,690 (2023 - £5,007,375) was due from the entities.

 

24
Cash generated from operations
2024
2023
£
£
Profit for the year after tax
1,029,771
1,681,530
Adjustments for:
Taxation charged
119,284
530,542
Finance costs
58,075
156,360
Investment income
(24)
(996)
Loss on disposal of tangible fixed assets
3,521
500
Depreciation and impairment of tangible fixed assets
332,770
352,682
Decrease in provisions
-
0
(375,000)
Movements in working capital:
Increase in stocks
(185,314)
(8,289)
Decrease in debtors
1,467,301
2,677,074
Increase/(decrease) in creditors
451,186
(3,624,321)
Cash generated from operations
3,276,570
1,390,082
NORTHWOOD TISSUE (DISLEY) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 30 -
25
Analysis of changes in net funds/(debt)
1 January 2024
Cash flows
31 December 2024
£
£
£
Cash at bank and in hand
235,362
(206,503)
28,859
Borrowings excluding overdrafts
(1,918,925)
1,918,925
-
(1,683,563)
1,712,422
28,859
2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.200Mr P FecherMr M FecherMr A FecherMr P KingMr C DaviesMr D HarriesMr P E King070223092024-01-012024-12-3107022309bus:Director12024-01-012024-12-3107022309bus:Director22024-01-012024-12-3107022309bus:Director32024-01-012024-12-3107022309bus:Director42024-01-012024-12-3107022309bus:Director52024-01-012024-12-3107022309bus:Director62024-01-012024-12-3107022309bus:CompanySecretary12024-01-012024-12-3107022309bus:RegisteredOffice2024-01-012024-12-31070223092024-12-31070223092023-01-012023-12-3107022309core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3107022309core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3107022309core:RevaluationReserve2024-01-012024-12-3107022309core:RevaluationReserve2023-01-012023-12-3107022309core:RevenueReservesInvestmentFundsOnly2023-01-012023-12-31070223092023-12-3107022309core:ConstructionInProgressAssetsUnderConstruction2024-12-3107022309core:PlantMachinery2024-12-3107022309core:ConstructionInProgressAssetsUnderConstruction2023-12-3107022309core:PlantMachinery2023-12-3107022309core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3107022309core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3107022309core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3107022309core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3107022309core:CurrentFinancialInstruments2024-12-3107022309core:CurrentFinancialInstruments2023-12-3107022309core:ShareCapital2024-12-3107022309core:ShareCapital2023-12-3107022309core:SharePremium2024-12-3107022309core:SharePremium2023-12-3107022309core:RevaluationReserve2024-12-3107022309core:RevaluationReserve2023-12-3107022309core:RetainedEarningsAccumulatedLosses2024-12-3107022309core:RetainedEarningsAccumulatedLosses2023-12-3107022309core:ShareCapital2022-12-3107022309core:SharePremium2022-12-3107022309core:RevaluationReserve2022-12-3107022309core:RetainedEarningsAccumulatedLosses2022-12-3107022309core:ShareCapitalOrdinaryShareClass12024-12-3107022309core:ShareCapitalOrdinaryShareClass12023-12-31070223092023-12-31070223092022-12-3107022309core:PlantMachinery2024-01-012024-12-310702230912024-01-012024-12-310702230912023-01-012023-12-3107022309core:UKTax2024-01-012024-12-3107022309core:UKTax2023-01-012023-12-3107022309core:ConstructionInProgressAssetsUnderConstruction2023-12-3107022309core:PlantMachinery2023-12-3107022309core:ConstructionInProgressAssetsUnderConstruction2024-01-012024-12-3107022309core:Non-currentFinancialInstruments2024-12-3107022309core:Non-currentFinancialInstruments2023-12-3107022309bus:OrdinaryShareClass12024-01-012024-12-3107022309bus:OrdinaryShareClass12024-12-3107022309bus:OrdinaryShareClass12023-12-3107022309core:WithinOneYear2024-12-3107022309core:BetweenTwoFiveYears2024-12-3107022309bus:PrivateLimitedCompanyLtd2024-01-012024-12-3107022309bus:FRS1022024-01-012024-12-3107022309bus:Audited2024-01-012024-12-3107022309bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP